Page last updated: 2024-08-22

didodecyldimethylammonium and Colonic Neoplasms

didodecyldimethylammonium has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fathi, M; Nedaei, K; Ramazani, A; Rostamizadeh, K; Shahidi, S1

Other Studies

1 other study(ies) available for didodecyldimethylammonium and Colonic Neoplasms

ArticleYear
Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells.
    BMC complementary medicine and therapies, 2022, Dec-27, Volume: 22, Issue:1

    Topics: Colonic Neoplasms; Humans; Nanoparticles; Quercetin; RNA, Small Interfering

2022